Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies.
暂无分享,去创建一个
M. Grever | J. Byrd | I. Flinn | S. Piantadosi | R. Ambinder | G. Vogelsang | L. Diehl | E. Seifter | Candis Morrison | T. Murphy | J. Jamison | C. Morrison | J. Jamison
[1] P. Bierman. Allogeneic bone marrow transplantation for lymphoma. , 2000, Blood reviews.
[2] J. Byrd,et al. Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history study , 1999, British journal of haematology.
[3] J. Koziol,et al. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. , 1998, Blood.
[4] J. Armitage,et al. Allogeneic bone marrow transplantation for low-grade lymphoma. , 1998, Blood.
[5] Bolam,et al. Association of myelodysplastic changes with purine analogues , 1998, British journal of haematology.
[6] M. Grever,et al. Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals. , 1998, Seminars in oncology.
[7] J. Pullen,et al. Biology and treatment of acute lymphocytic leukemia in children. , 1997, Seminars in oncology.
[8] J. Gribben,et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. , 1996, Blood.
[9] D. Seiffert,et al. Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules. , 1996, Blood.
[10] M. Grever,et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.
[11] P. Mclaughlin,et al. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] W. Plunkett,et al. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair. , 1995, Molecular pharmacology.
[13] E. Berman,et al. Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia. , 1994, Leukemia.
[14] J. Johnston,et al. Combination therapy with nucleoside analogs and alkylating agents. , 1994, Leukemia.
[15] S. Horning. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. , 1993, Seminars in oncology.
[16] E. Estey,et al. Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies. , 1993, Seminars in oncology.
[17] M. Grever,et al. A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study. , 1993, Leukemia.
[18] M. Grever,et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group , 1988, American journal of hematology.
[19] M Tubiana,et al. Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.
[20] D C Case,et al. Clinical staging of chronic lymphocytic leukemia. , 1977, The Journal of the Maine Medical Association.